Спинална мишићна атрофија (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Спинална мишићна атрофија" in Serbian language version.
refsWebsite
Global rank
Serbian rank
11th place
23rd place
6th place
5th place
5,181st place
6,243rd place
5th place
12th place
18th place
28th place
low place
low place
1st place
1st place
low place
low place
1,581st place
1,760th place
low place
low place
low place
low place
610th place
653rd place
low place
low place
low place
low place
3,823rd place
low place
3,771st place
8,311th place
4,502nd place
36th place
acog.org (Global: low place; Serbian: low place)
- „Carrier Screening in the Age of Genomic Medicine – ACOG”. www.acog.org. Архивирано из оригинала 25. 02. 2017. г. Приступљено 24. 2. 2017.
archive.org (Global: 6th place; Serbian: 5th place)
- Brzustowicz LM, Lehner T, Castilla LH, Penchaszadeh GK, Wilhelmsen KC, Daniels R, Davies KE, Leppert M, Ziter F, Wood D (април 1990). „Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2–13.3”. Nature. 344 (6266): 540—1. Bibcode:1990Natur.344..540B. PMID 2320125. S2CID 4259327. doi:10.1038/344540a0.
- Bach JR, Niranjan V, Weaver B (април 2000). „Spinal muscular atrophy type 1: A noninvasive respiratory management approach”. Chest. 117 (4): 1100—5. PMID 10767247. doi:10.1378/chest.117.4.1100.
- Bach JR, Saltstein K, Sinquee D, Weaver B, Komaroff E (мај 2007). „Long-term survival in Werdnig-Hoffmann disease”. American Journal of Physical Medicine & Rehabilitation. 86 (5): 339—45 quiz 346—8, 379. PMID 17449977. S2CID 9942245. doi:10.1097/PHM.0b013e31804a8505.
- Tein I, Sloane AE, Donner EJ, Lehotay DC, Millington DS, Kelley RI (јануар 1995). „Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?”. Pediatric Neurology. 12 (1): 21—30. PMID 7748356. doi:10.1016/0887-8994(94)00100-G.
- Bach JR (мај 2007). „Medical considerations of long-term survival of Werdnig-Hoffmann disease”. American Journal of Physical Medicine & Rehabilitation. 86 (5): 349—55. PMID 17449979. S2CID 39989993. doi:10.1097/PHM.0b013e31804b1d66.
- Oskoui M, Levy G, Garland CJ, Gray JM, O'Hagen J, De Vivo DC, Kaufmann P (новембар 2007). „The changing natural history of spinal muscular atrophy type 1”. Neurology. 69 (20): 1931—6. PMID 17998484. S2CID 7528894. doi:10.1212/01.wnl.0000290830.40544.b9.
childrenshospital.org (Global: low place; Serbian: low place)
- „Spinal Muscular Atrophy (SMA) | Boston Children's Hospital”. www.childrenshospital.org. Приступљено 2020-10-25.
childrensnational.org (Global: low place; Serbian: low place)
- „Spinal Muscular Atrophy – Conditions | Children's National”. childrensnational.org. Приступљено 2020-10-25.
curesma.org (Global: low place; Serbian: low place)
- McCall, Sarah. „Newborn Screening for Spinal Muscular Atrophy”. Cure SMA (на језику: енглески). Приступљено 2020-05-04.
- Apkon, Susan (лето 2017). „SMA CARE SERIES – Musculoskeletal System” (PDF). www.curesma.org. Архивирано из оригинала (PDF) 19. 02. 2018. г. Приступљено 25. 02. 2022.
doi.org (Global: 2nd place; Serbian: 4th place)
- Verhaart, Ingrid E. C.; Robertson, Agata; Leary, Rebecca; McMacken, Grace; König, Kirsten; Kirschner, Janbernd; Jones, Cynthia C.; Cook, Suzanne F.; Lochmüller, Hanns (јул 2017). „A multi-source approach to determine SMA incidence and research ready population”. Journal of Neurology (на језику: енглески). 264 (7): 1465—1473. ISSN 0340-5354. PMC 5502065
. PMID 28634652. doi:10.1007/s00415-017-8549-1. - Dubowitz, Victor (2009). „Ramblings in the history of spinal muscular atrophy”. Neuromuscular Disorders (на језику: енглески). 19 (1): 69—73. PMID 18951794. S2CID 37576912. doi:10.1016/j.nmd.2008.10.004.
- Brzustowicz LM, Lehner T, Castilla LH, Penchaszadeh GK, Wilhelmsen KC, Daniels R, Davies KE, Leppert M, Ziter F, Wood D (април 1990). „Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2–13.3”. Nature. 344 (6266): 540—1. Bibcode:1990Natur.344..540B. PMID 2320125. S2CID 4259327. doi:10.1038/344540a0.
- Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M (јануар 1995). „Identification and characterization of a spinal muscular atrophy-determining gene”. Cell. 80 (1): 155—65. PMID 7813012. S2CID 14291056. doi:10.1016/0092-8674(95)90460-3 .
- Passini MA, Bu J, Richards AM, Kinnecom C, Sardi SP, Stanek LM, Hua Y, Rigo F, Matson J, Hung G, Kaye EM, Shihabuddin LS, Krainer AR, Bennett CF, Cheng SH (март 2011). „Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy”. Science Translational Medicine. 3 (72): 72ra18. PMC 3140425 . PMID 21368223. doi:10.1126/scitranslmed.3001777.
- Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B, Aloysius A, Morrison L, Main M, Crawford TO, Trela A (август 2007). „Consensus statement for standard of care in spinal muscular atrophy”. Journal of Child Neurology. 22 (8): 1027—49. PMID 17761659. S2CID 6478040. doi:10.1177/0883073807305788.
- Jedrzejowska M, Milewski M, Zimowski J, Borkowska J, Kostera-Pruszczyk A, Sielska D, Jurek M, Hausmanowa-Petrusewicz I (2009). „Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease”. Acta Biochimica Polonica. 56 (1): 103—8. PMID 19287802. doi:10.18388/abp.2009_2521 .
- Su YN, Hung CC, Lin SY, Chen FY, Chern JP, Tsai C, Chang TS, Yang CC, Li H, Ho HN, Lee CN (фебруар 2011). Schrijver I, ур. „Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005–2009: a prospective population-based cohort study”. PLOS ONE. 6 (2): e17067. Bibcode:2011PLoSO...617067S. PMC 3045421 . PMID 21364876. doi:10.1371/journal.pone.0017067 .
- Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, Flynn K, Hendrickson BC, Scholl T, Sirko-Osadsa DA, Allitto BA (јануар 2012). „Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens”. European Journal of Human Genetics. 20 (1): 27—32. PMC 3234503 . PMID 21811307. doi:10.1038/ejhg.2011.134.
- Serra-Juhe C, Tizzano EF (децембар 2019). „Perspectives in genetic counseling for spinal muscular atrophy in the new therapeutic era: early pre-symptomatic intervention and test in minors”. European Journal of Human Genetics. 27 (12): 1774—1782. PMC 6871529 . PMID 31053787. doi:10.1038/s41431-019-0415-4.
- Glascock J, Sampson J, Haidet-Phillips A, Connolly A, Darras B, Day J, et al. (2018-05-29). „Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening”. Journal of Neuromuscular Diseases. 5 (2): 145—158. PMC 6004919 . PMID 29614695. doi:10.3233/JND-180304.
- Chien YH, Chiang SC, Weng WC, Lee NC, Lin CJ, Hsieh WS, et al. (новембар 2017). „Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening”. The Journal of Pediatrics. 190: 124—129.e1. PMID 28711173. S2CID 20621772. doi:10.1016/j.jpeds.2017.06.042.
- Kariyawasam DS, Russell JS, Wiley V, Alexander IE, Farrar MA (март 2020). „The implementation of newborn screening for spinal muscular atrophy: the Australian experience”. Genetics in Medicine. 22 (3): 557—565. PMID 31607747. S2CID 204459317. doi:10.1038/s41436-019-0673-0 .
- Boemer F, Caberg JH, Dideberg V, Dardenne D, Bours V, Hiligsmann M, et al. (мај 2019). „Newborn screening for SMA in Southern Belgium”. Neuromuscular Disorders. 29 (5): 343—349. PMID 31030938. S2CID 72332212. doi:10.1016/j.nmd.2019.02.003.
- Vill K, Kölbel H, Schwartz O, Blaschek A, Olgemöller B, Harms E, et al. (2019-10-31). „One Year of Newborn Screening for SMA – Results of a German Pilot Project”. Journal of Neuromuscular Diseases. 6 (4): 503—515. PMC 6918901 . PMID 31594245. doi:10.3233/JND-190428.
- Lin Y, Lin CH, Yin X, Zhu L, Yang J, Shen Y, et al. (2019). „Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry”. Frontiers in Genetics (на језику: енглески). 10: 1255. PMC 6928056 . PMID 31921298. doi:10.3389/fgene.2019.01255 .
- Shinohara M, Niba ET, Wijaya YO, Takayama I, Mitsuishi C, Kumasaka S, Kondo Y, Takatera A, Hokuto I, Morioka I, Ogiwara K (децембар 2019). „A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study”. International Journal of Neonatal Screening (на језику: енглески). 5 (4): 41. doi:10.3390/ijns5040041 .
- Nilay, M, Moirangthem, A, Saxena, D, Mandal, K, Phadke, SR (октобар 2020). „Carrier frequency of SMN1 related spinal muscular atrophy in north Indian population: The need for population based screening program.”. American Journal of Medical Genetics Part A. 185 (1): 274—277. S2CID 222353383. doi:10.1002/ajmg.a.61918.
- Ar Rochmah M, Awano H, Awaya T, Harahap NI, Morisada N, Bouike Y, Saito T, Kubo Y, Saito K, Lai PS, Morioka I, Iijima K, Nishio H, Shinohara M (новембар 2017). „Spinal muscular atrophy carriers with two SMN1 copies”. Brain & Development. 39 (10): 851—860. PMID 28676237. S2CID 26504674. doi:10.1016/j.braindev.2017.06.002.
- Prior TW (новембар 2008). „Carrier screening for spinal muscular atrophy”. Genetics in Medicine. 10 (11): 840—2. PMC 3110347 . PMID 18941424. doi:10.1097/GIM.0b013e318188d069.
- Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. (новембар 2017). „Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy”. New England Journal of Medicine. 377 (18): 1723—32. PMID 29091570. S2CID 4771819. doi:10.1056/NEJMoa1702752.
- Zhao X, Feng Z, Ling KK, Mollin A, Sheedy J, Yeh S, et al. (мај 2016). „Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy”. Human Molecular Genetics. 25 (10): 1885—1899. PMC 5062580 . PMID 26931466. doi:10.1093/hmg/ddw062.
- Bach JR, Niranjan V, Weaver B (април 2000). „Spinal muscular atrophy type 1: A noninvasive respiratory management approach”. Chest. 117 (4): 1100—5. PMID 10767247. doi:10.1378/chest.117.4.1100.
- Bach JR, Saltstein K, Sinquee D, Weaver B, Komaroff E (мај 2007). „Long-term survival in Werdnig-Hoffmann disease”. American Journal of Physical Medicine & Rehabilitation. 86 (5): 339—45 quiz 346—8, 379. PMID 17449977. S2CID 9942245. doi:10.1097/PHM.0b013e31804a8505.
- Messina S, Pane M, De Rose P, Vasta I, Sorleti D, Aloysius A, Sciarra F, Mangiola F, Kinali M, Bertini E, Mercuri E (мај 2008). „Feeding problems and malnutrition in spinal muscular atrophy type II”. Neuromuscular Disorders. 18 (5): 389—93. PMID 18420410. S2CID 23302291. doi:10.1016/j.nmd.2008.02.008.
- Tilton AH, Miller MD, Khoshoo V (јун 1998). „Nutrition and swallowing in pediatric neuromuscular patients”. Seminars in Pediatric Neurology. 5 (2): 106—15. PMID 9661244. doi:10.1016/S1071-9091(98)80026-0.
- Messina S, Pane M, De Rose P, Vasta I, Sorleti D, Aloysius A, Sciarra F, Mangiola F, Kinali M, Bertini E, Mercuri E (мај 2008). „Feeding problems and malnutrition in spinal muscular atrophy type II”. Neuromuscular Disorders. 18 (5): 389—93. PMID 18420410. S2CID 23302291. doi:10.1016/j.nmd.2008.02.008.
- Tein I, Sloane AE, Donner EJ, Lehotay DC, Millington DS, Kelley RI (јануар 1995). „Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?”. Pediatric Neurology. 12 (1): 21—30. PMID 7748356. doi:10.1016/0887-8994(94)00100-G.
- Yuan N, Wang CH, Trela A, Albanese CT (јун 2007). „Laparoscopic Nissen fundoplication during gastrostomy tube placement and noninvasive ventilation may improve survival in type I and severe type II spinal muscular atrophy”. Journal of Child Neurology. 22 (6): 727—31. PMID 17641258. S2CID 38799022. doi:10.1177/0883073807304009.
- Bach JR (мај 2007). „Medical considerations of long-term survival of Werdnig-Hoffmann disease”. American Journal of Physical Medicine & Rehabilitation. 86 (5): 349—55. PMID 17449979. S2CID 39989993. doi:10.1097/PHM.0b013e31804b1d66.
- Oskoui M, Levy G, Garland CJ, Gray JM, O'Hagen J, De Vivo DC, Kaufmann P (новембар 2007). „The changing natural history of spinal muscular atrophy type 1”. Neurology. 69 (20): 1931—6. PMID 17998484. S2CID 7528894. doi:10.1212/01.wnl.0000290830.40544.b9.
elsevier.com (Global: 610th place; Serbian: 653rd place)
linkinghub.elsevier.com
- Dubowitz, Victor (2009). „Ramblings in the history of spinal muscular atrophy”. Neuromuscular Disorders (на језику: енглески). 19 (1): 69—73. PMID 18951794. S2CID 37576912. doi:10.1016/j.nmd.2008.10.004.
europa.eu (Global: 68th place; Serbian: 107th place)
ema.europa.eu
- „Spinraza EPAR”. European Medicines Agency (EMA). Приступљено 8. 8. 2020.
- „Zolgensma EPAR”. European Medicines Agency (EMA). 24. 3. 2020. Приступљено 8. 8. 2020.
fda.gov (Global: 447th place; Serbian: 925th place)
fda.gov
- „FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality”. FDA (на језику: енглески). 24. 5. 2019. Приступљено 27. 5. 2019.
- „FDA Approves Oral Treatment for Spinal Muscular Atrophy”. U.S. Food and Drug Administration (FDA) (Саопштење). 7. 8. 2020. Приступљено 7. 8. 2020.
- „FDA Approves Oral Treatment for Spinal Muscular Atrophy”. U.S. Food and Drug Administration (FDA) (Саопштење). 7. 8. 2020. Приступљено 7. 8. 2020.
accessdata.fda.gov
- „Spinraza (nusinersen) Injection”. U.S. Food and Drug Administration (FDA). 18. 1. 2017. Приступљено 8. 8. 2020.
harvard.edu (Global: 18th place; Serbian: 28th place)
adsabs.harvard.edu
- Brzustowicz LM, Lehner T, Castilla LH, Penchaszadeh GK, Wilhelmsen KC, Daniels R, Davies KE, Leppert M, Ziter F, Wood D (април 1990). „Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2–13.3”. Nature. 344 (6266): 540—1. Bibcode:1990Natur.344..540B. PMID 2320125. S2CID 4259327. doi:10.1038/344540a0.
- Su YN, Hung CC, Lin SY, Chen FY, Chern JP, Tsai C, Chang TS, Yang CC, Li H, Ho HN, Lee CN (фебруар 2011). Schrijver I, ур. „Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005–2009: a prospective population-based cohort study”. PLOS ONE. 6 (2): e17067. Bibcode:2011PLoSO...617067S. PMC 3045421 . PMID 21364876. doi:10.1371/journal.pone.0017067 .
healthcouncil.nl (Global: low place; Serbian: low place)
- Ministerie van Volksgezondheid, Welzijn en Sport (2019-07-23). „Neonatal screening for spinal muscular atrophy – Advisory report – The Health Council of the Netherlands”. www.healthcouncil.nl (на језику: енглески). Приступљено 2020-05-04.
maastrichtuniversity.nl (Global: low place; Serbian: low place)
cris.maastrichtuniversity.nl
- Boemer F, Caberg JH, Dideberg V, Dardenne D, Bours V, Hiligsmann M, et al. (мај 2019). „Newborn screening for SMA in Southern Belgium”. Neuromuscular Disorders. 29 (5): 343—349. PMID 31030938. S2CID 72332212. doi:10.1016/j.nmd.2019.02.003.
mda.org (Global: low place; Serbian: low place)
strongly.mda.org
- Stephenson, Kristin (2018-07-05). „SMA Added to National List of Disorders to Screen for at Birth”. Muscular Dystrophy Association (на језику: енглески). Приступљено 2020-05-04.
medicines.org.uk (Global: 3,823rd place; Serbian: low place)
- „Zolgensma 2 x 1013 vector genomes/mL solution for infusion”. www.medicines.org.uk. Приступљено 8. 8. 2020.
medlineplus.gov (Global: 1,581st place; Serbian: 1,760th place)
- „Spinal muscular atrophy: MedlinePlus Genetics”. medlineplus.gov (на језику: енглески). Приступљено 2020-10-24.
n1info.com (Global: 4,502nd place; Serbian: 36th place)
rs.n1info.com
- „Spinalna mišićna atrofija”. N1 (на језику: српски). 2020-08-16. Приступљено 2022-02-25.
nhs.uk (Global: 1,989th place; Serbian: 1,344th place)
- „Spinal muscular atrophy”. nhs.uk (на језику: енглески). 2017-10-23. Приступљено 2020-10-24.
nih.gov (Global: 4th place; Serbian: 8th place)
ncbi.nlm.nih.gov
- Prior, Thomas W.; Leach, Meganne E.; Finanger, Erika (1993), Adam, Margaret P.; Ardinger, Holly H.; Pagon, Roberta A.; Wallace, Stephanie E., ур., „Spinal Muscular Atrophy”, GeneReviews®, Seattle (WA): University of Washington, Seattle, PMID 20301526, Приступљено 2020-10-25
- Verhaart, Ingrid E. C.; Robertson, Agata; Leary, Rebecca; McMacken, Grace; König, Kirsten; Kirschner, Janbernd; Jones, Cynthia C.; Cook, Suzanne F.; Lochmüller, Hanns (јул 2017). „A multi-source approach to determine SMA incidence and research ready population”. Journal of Neurology (на језику: енглески). 264 (7): 1465—1473. ISSN 0340-5354. PMC 5502065 . PMID 28634652. doi:10.1007/s00415-017-8549-1.
- Dubowitz, Victor (2009). „Ramblings in the history of spinal muscular atrophy”. Neuromuscular Disorders (на језику: енглески). 19 (1): 69—73. PMID 18951794. S2CID 37576912. doi:10.1016/j.nmd.2008.10.004.
- Brzustowicz LM, Lehner T, Castilla LH, Penchaszadeh GK, Wilhelmsen KC, Daniels R, Davies KE, Leppert M, Ziter F, Wood D (април 1990). „Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2–13.3”. Nature. 344 (6266): 540—1. Bibcode:1990Natur.344..540B. PMID 2320125. S2CID 4259327. doi:10.1038/344540a0.
- Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M (јануар 1995). „Identification and characterization of a spinal muscular atrophy-determining gene”. Cell. 80 (1): 155—65. PMID 7813012. S2CID 14291056. doi:10.1016/0092-8674(95)90460-3 .
- Passini MA, Bu J, Richards AM, Kinnecom C, Sardi SP, Stanek LM, Hua Y, Rigo F, Matson J, Hung G, Kaye EM, Shihabuddin LS, Krainer AR, Bennett CF, Cheng SH (март 2011). „Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy”. Science Translational Medicine. 3 (72): 72ra18. PMC 3140425 . PMID 21368223. doi:10.1126/scitranslmed.3001777.
- Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B, Aloysius A, Morrison L, Main M, Crawford TO, Trela A (август 2007). „Consensus statement for standard of care in spinal muscular atrophy”. Journal of Child Neurology. 22 (8): 1027—49. PMID 17761659. S2CID 6478040. doi:10.1177/0883073807305788.
- Jedrzejowska M, Milewski M, Zimowski J, Borkowska J, Kostera-Pruszczyk A, Sielska D, Jurek M, Hausmanowa-Petrusewicz I (2009). „Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease”. Acta Biochimica Polonica. 56 (1): 103—8. PMID 19287802. doi:10.18388/abp.2009_2521 .
- Su YN, Hung CC, Lin SY, Chen FY, Chern JP, Tsai C, Chang TS, Yang CC, Li H, Ho HN, Lee CN (фебруар 2011). Schrijver I, ур. „Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005–2009: a prospective population-based cohort study”. PLOS ONE. 6 (2): e17067. Bibcode:2011PLoSO...617067S. PMC 3045421 . PMID 21364876. doi:10.1371/journal.pone.0017067 .
- Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, Flynn K, Hendrickson BC, Scholl T, Sirko-Osadsa DA, Allitto BA (јануар 2012). „Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens”. European Journal of Human Genetics. 20 (1): 27—32. PMC 3234503 . PMID 21811307. doi:10.1038/ejhg.2011.134.
- Serra-Juhe C, Tizzano EF (децембар 2019). „Perspectives in genetic counseling for spinal muscular atrophy in the new therapeutic era: early pre-symptomatic intervention and test in minors”. European Journal of Human Genetics. 27 (12): 1774—1782. PMC 6871529 . PMID 31053787. doi:10.1038/s41431-019-0415-4.
- Glascock J, Sampson J, Haidet-Phillips A, Connolly A, Darras B, Day J, et al. (2018-05-29). „Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening”. Journal of Neuromuscular Diseases. 5 (2): 145—158. PMC 6004919 . PMID 29614695. doi:10.3233/JND-180304.
- Chien YH, Chiang SC, Weng WC, Lee NC, Lin CJ, Hsieh WS, et al. (новембар 2017). „Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening”. The Journal of Pediatrics. 190: 124—129.e1. PMID 28711173. S2CID 20621772. doi:10.1016/j.jpeds.2017.06.042.
- Kariyawasam DS, Russell JS, Wiley V, Alexander IE, Farrar MA (март 2020). „The implementation of newborn screening for spinal muscular atrophy: the Australian experience”. Genetics in Medicine. 22 (3): 557—565. PMID 31607747. S2CID 204459317. doi:10.1038/s41436-019-0673-0 .
- Boemer F, Caberg JH, Dideberg V, Dardenne D, Bours V, Hiligsmann M, et al. (мај 2019). „Newborn screening for SMA in Southern Belgium”. Neuromuscular Disorders. 29 (5): 343—349. PMID 31030938. S2CID 72332212. doi:10.1016/j.nmd.2019.02.003.
- Vill K, Kölbel H, Schwartz O, Blaschek A, Olgemöller B, Harms E, et al. (2019-10-31). „One Year of Newborn Screening for SMA – Results of a German Pilot Project”. Journal of Neuromuscular Diseases. 6 (4): 503—515. PMC 6918901 . PMID 31594245. doi:10.3233/JND-190428.
- Lin Y, Lin CH, Yin X, Zhu L, Yang J, Shen Y, et al. (2019). „Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry”. Frontiers in Genetics (на језику: енглески). 10: 1255. PMC 6928056 . PMID 31921298. doi:10.3389/fgene.2019.01255 .
- Ar Rochmah M, Awano H, Awaya T, Harahap NI, Morisada N, Bouike Y, Saito T, Kubo Y, Saito K, Lai PS, Morioka I, Iijima K, Nishio H, Shinohara M (новембар 2017). „Spinal muscular atrophy carriers with two SMN1 copies”. Brain & Development. 39 (10): 851—860. PMID 28676237. S2CID 26504674. doi:10.1016/j.braindev.2017.06.002.
- Prior TW (новембар 2008). „Carrier screening for spinal muscular atrophy”. Genetics in Medicine. 10 (11): 840—2. PMC 3110347 . PMID 18941424. doi:10.1097/GIM.0b013e318188d069.
- Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. (новембар 2017). „Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy”. New England Journal of Medicine. 377 (18): 1723—32. PMID 29091570. S2CID 4771819. doi:10.1056/NEJMoa1702752.
- Zhao X, Feng Z, Ling KK, Mollin A, Sheedy J, Yeh S, et al. (мај 2016). „Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy”. Human Molecular Genetics. 25 (10): 1885—1899. PMC 5062580 . PMID 26931466. doi:10.1093/hmg/ddw062.
- Bach JR, Niranjan V, Weaver B (април 2000). „Spinal muscular atrophy type 1: A noninvasive respiratory management approach”. Chest. 117 (4): 1100—5. PMID 10767247. doi:10.1378/chest.117.4.1100.
- Bach JR, Saltstein K, Sinquee D, Weaver B, Komaroff E (мај 2007). „Long-term survival in Werdnig-Hoffmann disease”. American Journal of Physical Medicine & Rehabilitation. 86 (5): 339—45 quiz 346—8, 379. PMID 17449977. S2CID 9942245. doi:10.1097/PHM.0b013e31804a8505.
- Messina S, Pane M, De Rose P, Vasta I, Sorleti D, Aloysius A, Sciarra F, Mangiola F, Kinali M, Bertini E, Mercuri E (мај 2008). „Feeding problems and malnutrition in spinal muscular atrophy type II”. Neuromuscular Disorders. 18 (5): 389—93. PMID 18420410. S2CID 23302291. doi:10.1016/j.nmd.2008.02.008.
- Tilton AH, Miller MD, Khoshoo V (јун 1998). „Nutrition and swallowing in pediatric neuromuscular patients”. Seminars in Pediatric Neurology. 5 (2): 106—15. PMID 9661244. doi:10.1016/S1071-9091(98)80026-0.
- Messina S, Pane M, De Rose P, Vasta I, Sorleti D, Aloysius A, Sciarra F, Mangiola F, Kinali M, Bertini E, Mercuri E (мај 2008). „Feeding problems and malnutrition in spinal muscular atrophy type II”. Neuromuscular Disorders. 18 (5): 389—93. PMID 18420410. S2CID 23302291. doi:10.1016/j.nmd.2008.02.008.
- Tein I, Sloane AE, Donner EJ, Lehotay DC, Millington DS, Kelley RI (јануар 1995). „Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?”. Pediatric Neurology. 12 (1): 21—30. PMID 7748356. doi:10.1016/0887-8994(94)00100-G.
- Yuan N, Wang CH, Trela A, Albanese CT (јун 2007). „Laparoscopic Nissen fundoplication during gastrostomy tube placement and noninvasive ventilation may improve survival in type I and severe type II spinal muscular atrophy”. Journal of Child Neurology. 22 (6): 727—31. PMID 17641258. S2CID 38799022. doi:10.1177/0883073807304009.
- Bach JR (мај 2007). „Medical considerations of long-term survival of Werdnig-Hoffmann disease”. American Journal of Physical Medicine & Rehabilitation. 86 (5): 349—55. PMID 17449979. S2CID 39989993. doi:10.1097/PHM.0b013e31804b1d66.
- Oskoui M, Levy G, Garland CJ, Gray JM, O'Hagen J, De Vivo DC, Kaufmann P (новембар 2007). „The changing natural history of spinal muscular atrophy type 1”. Neurology. 69 (20): 1931—6. PMID 17998484. S2CID 7528894. doi:10.1212/01.wnl.0000290830.40544.b9.
dailymed.nlm.nih.gov
- „Spinraza- nusinersen injection, solution”. DailyMed. 30. 6. 2020. Приступљено 8. 8. 2020.
- „Spinraza- nusinersen injection, solution”. DailyMed. 30. 6. 2020. Приступљено 8. 8. 2020.
- „Zolgensma- onasemnogene abeparvovec-xioi kit”. DailyMed. 24. 5. 2019. Приступљено 8. 8. 2020.
ghr.nlm.nih.gov
- „Spinal muscular atrophy”. Genetics Home Reference (на језику: енглески). Приступљено 27. 5. 2019.
- „Spinal muscular atrophy”. Genetics Home Reference. Приступљено 2019-05-15.
rarediseases.info.nih.gov
- „Spinal muscular atrophy”. Genetic and Rare Diseases Information Center (GARD) – an NCATS Program. Приступљено 27. 5. 2019.
ninds.nih.gov
- „Spinal Muscular Atrophy Fact Sheet | National Institute of Neurological Disorders and Stroke”. NINDS. Приступљено 27. 5. 2019.
rarediseases.org (Global: 5,181st place; Serbian: 6,243rd place)
- „Spinal Muscular Atrophy”. NORD (National Organization for Rare Disorders). Приступљено 27. 5. 2019.
- „Spinal Muscular Atrophy”. NORD (National Organization for Rare Disorders). Приступљено 27. 5. 2019.
semanticscholar.org (Global: 11th place; Serbian: 23rd place)
api.semanticscholar.org
- Dubowitz, Victor (2009). „Ramblings in the history of spinal muscular atrophy”. Neuromuscular Disorders (на језику: енглески). 19 (1): 69—73. PMID 18951794. S2CID 37576912. doi:10.1016/j.nmd.2008.10.004.
- Brzustowicz LM, Lehner T, Castilla LH, Penchaszadeh GK, Wilhelmsen KC, Daniels R, Davies KE, Leppert M, Ziter F, Wood D (април 1990). „Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2–13.3”. Nature. 344 (6266): 540—1. Bibcode:1990Natur.344..540B. PMID 2320125. S2CID 4259327. doi:10.1038/344540a0.
- Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M (јануар 1995). „Identification and characterization of a spinal muscular atrophy-determining gene”. Cell. 80 (1): 155—65. PMID 7813012. S2CID 14291056. doi:10.1016/0092-8674(95)90460-3 .
- Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B, Aloysius A, Morrison L, Main M, Crawford TO, Trela A (август 2007). „Consensus statement for standard of care in spinal muscular atrophy”. Journal of Child Neurology. 22 (8): 1027—49. PMID 17761659. S2CID 6478040. doi:10.1177/0883073807305788.
- Chien YH, Chiang SC, Weng WC, Lee NC, Lin CJ, Hsieh WS, et al. (новембар 2017). „Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening”. The Journal of Pediatrics. 190: 124—129.e1. PMID 28711173. S2CID 20621772. doi:10.1016/j.jpeds.2017.06.042.
- Kariyawasam DS, Russell JS, Wiley V, Alexander IE, Farrar MA (март 2020). „The implementation of newborn screening for spinal muscular atrophy: the Australian experience”. Genetics in Medicine. 22 (3): 557—565. PMID 31607747. S2CID 204459317. doi:10.1038/s41436-019-0673-0 .
- Boemer F, Caberg JH, Dideberg V, Dardenne D, Bours V, Hiligsmann M, et al. (мај 2019). „Newborn screening for SMA in Southern Belgium”. Neuromuscular Disorders. 29 (5): 343—349. PMID 31030938. S2CID 72332212. doi:10.1016/j.nmd.2019.02.003.
- Nilay, M, Moirangthem, A, Saxena, D, Mandal, K, Phadke, SR (октобар 2020). „Carrier frequency of SMN1 related spinal muscular atrophy in north Indian population: The need for population based screening program.”. American Journal of Medical Genetics Part A. 185 (1): 274—277. S2CID 222353383. doi:10.1002/ajmg.a.61918.
- Ar Rochmah M, Awano H, Awaya T, Harahap NI, Morisada N, Bouike Y, Saito T, Kubo Y, Saito K, Lai PS, Morioka I, Iijima K, Nishio H, Shinohara M (новембар 2017). „Spinal muscular atrophy carriers with two SMN1 copies”. Brain & Development. 39 (10): 851—860. PMID 28676237. S2CID 26504674. doi:10.1016/j.braindev.2017.06.002.
- Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. (новембар 2017). „Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy”. New England Journal of Medicine. 377 (18): 1723—32. PMID 29091570. S2CID 4771819. doi:10.1056/NEJMoa1702752.
- Bach JR, Saltstein K, Sinquee D, Weaver B, Komaroff E (мај 2007). „Long-term survival in Werdnig-Hoffmann disease”. American Journal of Physical Medicine & Rehabilitation. 86 (5): 339—45 quiz 346—8, 379. PMID 17449977. S2CID 9942245. doi:10.1097/PHM.0b013e31804a8505.
- Messina S, Pane M, De Rose P, Vasta I, Sorleti D, Aloysius A, Sciarra F, Mangiola F, Kinali M, Bertini E, Mercuri E (мај 2008). „Feeding problems and malnutrition in spinal muscular atrophy type II”. Neuromuscular Disorders. 18 (5): 389—93. PMID 18420410. S2CID 23302291. doi:10.1016/j.nmd.2008.02.008.
- Messina S, Pane M, De Rose P, Vasta I, Sorleti D, Aloysius A, Sciarra F, Mangiola F, Kinali M, Bertini E, Mercuri E (мај 2008). „Feeding problems and malnutrition in spinal muscular atrophy type II”. Neuromuscular Disorders. 18 (5): 389—93. PMID 18420410. S2CID 23302291. doi:10.1016/j.nmd.2008.02.008.
- Yuan N, Wang CH, Trela A, Albanese CT (јун 2007). „Laparoscopic Nissen fundoplication during gastrostomy tube placement and noninvasive ventilation may improve survival in type I and severe type II spinal muscular atrophy”. Journal of Child Neurology. 22 (6): 727—31. PMID 17641258. S2CID 38799022. doi:10.1177/0883073807304009.
- Bach JR (мај 2007). „Medical considerations of long-term survival of Werdnig-Hoffmann disease”. American Journal of Physical Medicine & Rehabilitation. 86 (5): 349—55. PMID 17449979. S2CID 39989993. doi:10.1097/PHM.0b013e31804b1d66.
- Oskoui M, Levy G, Garland CJ, Gray JM, O'Hagen J, De Vivo DC, Kaufmann P (новембар 2007). „The changing natural history of spinal muscular atrophy type 1”. Neurology. 69 (20): 1931—6. PMID 17998484. S2CID 7528894. doi:10.1212/01.wnl.0000290830.40544.b9.
smasrbija.rs (Global: low place; Serbian: low place)
- „ŠTA JE SMA? - Udruženje obolelih od spinalne mišićne atrofije”. Udruženje SMA Srbija (на језику: српски). Приступљено 2022-02-25.
ucl.ac.uk (Global: 1,306th place; Serbian: 1,905th place)
discovery.ucl.ac.uk
- Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. (новембар 2017). „Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy”. New England Journal of Medicine. 377 (18): 1723—32. PMID 29091570. S2CID 4771819. doi:10.1056/NEJMoa1702752.
uptodate.com (Global: 3,771st place; Serbian: 8,311th place)
- Bodamer, Olaf (новембар 2017). „Spinal Muscular Atrophy”. uptodate.com. Приступљено 1. 12. 2017.
web.archive.org (Global: 1st place; Serbian: 1st place)
- „Carrier Screening in the Age of Genomic Medicine – ACOG”. www.acog.org. Архивирано из оригинала 25. 02. 2017. г. Приступљено 24. 2. 2017.
- Apkon, Susan (лето 2017). „SMA CARE SERIES – Musculoskeletal System” (PDF). www.curesma.org. Архивирано из оригинала (PDF) 19. 02. 2018. г. Приступљено 25. 02. 2022.
worldcat.org (Global: 5th place; Serbian: 12th place)
- Verhaart, Ingrid E. C.; Robertson, Agata; Leary, Rebecca; McMacken, Grace; König, Kirsten; Kirschner, Janbernd; Jones, Cynthia C.; Cook, Suzanne F.; Lochmüller, Hanns (јул 2017). „A multi-source approach to determine SMA incidence and research ready population”. Journal of Neurology (на језику: енглески). 264 (7): 1465—1473. ISSN 0340-5354. PMC 5502065 . PMID 28634652. doi:10.1007/s00415-017-8549-1.
- Charlotte J. Sumner, Sergey Paushkin, Chien-Ping Ko (2017). Spinal muscular atrophy : disease mechanisms and therapy. London. ISBN 978-0-12-803686-0. OCLC 961272280.